MJFF announced an exciting second study to test Nilotinib ( The approved drug used for Cronic Myelogenous leukemia), repurposed for people with Parkinson's. This study is called Nilo-PD. It's restricted to the USA, they're looking for 75 PEOPLE with Parkinson's, between the ages of 40 to 79, who have moderate to advanced PD (Diagnosed five+ years).
To find out if you qualify and would like to participate log into Fox Trial Finder foxtrialfinder.michaeljfox.com
Tell them Toni referred you.